Anixa Biosciences Inc Net Income per Employee (ANIX), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Anixa Biosciences Inc   (NASDAQ: ANIX)
 

Anixa Biosciences Inc Net Income per Employee

ANIX's Quarterly Results, Trends, Rankings, Statistics
Anixa Biosciences Inc recorded a cumulative net loss of $-10 million during 12 month ending in the third quarter 2026.
The Healthcare sector has seen employees of 376 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 4079, from total ranking in previous quarter at 4723.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANIX Net Income per Employee (Jul 31 2026)
III. Quarter		 (Apr 30 2026)
II. Quarter		 (Jan 31 2026)
I. Quarter		 (Oct 31 2025)
IV. Quarter		 (Jul 31 2025)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -2,617,000 -2,530,750 -2,600,000 -2,757,000 -2,804,750
ANIX's Total Ranking # 4079 # 4723 # 4269 # 4342 # 4392
Seq. Net Income Change - - - - -

ANIX Company Profile >> Back to ANIX Efficiency Comparisons >> Compare ANIX Net Income per Employee to its Competitors

ANIX Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 377
Healthcare Sector # 822
Overall Market # 4079

Net Income per Employee Statistics
High Average Low
$ -306,724 $ -2,385,109 $ -4,631,660
(Apr 30 2015)   (Apr 30 2019)




  News about Anixa Biosciences Inc Income per employee

Anixa Biosciences Inc. Sees Resilient Performance Amid Recent Developments

: Anixa Biosciences Inc. (NASDAQ: ANIX), a biotechnology firm dedicated to cancer treatment and prevention, is garnering attention as one of the top performers in the market this week. Despite a slight decline of 0.29% in overall performance this month, the company’s recent announcements, including patent advancements and a stock repurchase program, indicate a promising outlook for investors. In a landscape characterized by volatility, Anixa Biosciences Inc. has emerged as a notable player, maintaining a competitive presence in the biotechnology sector. With a market capitalization of approximately $80.3 million, the company has advised shareholders of its strategic decisions and recent advancements, solidifying its position as a leader in innovative cancer therapies.




Companies with similar Income per Employee for 12 month ending Jul 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Jul 31 2026Number of Employees Jul 31 2026


Date modified: 2026-09-12T14:11:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.